Aseptia, Inc.

Aseptia, Inc. is a provider of innovative processing solutions that enhance food quality and shelf life, focusing on delivering advanced preservation techniques for the food industry. Aseptia, Inc. specializes in food preservation technology and was founded in 2006 in Troy, US.

The company has undergone significant changes, including a focus shift towards enhancing food quality through innovative processing solutions. In March 2014, Aseptia completed a Series C funding round, raising USD 22. 00 mn from investors including F. B.

Heron Foundation, Lookout Capital, and Prudential Venture Capital Management. Aseptia has raised a total of USD 22. 00 mn across its funding rounds. Aseptia, Inc.

offers a range of advanced food preservation solutions tailored for the food industry. Their primary service includes innovative processing techniques that extend the shelf life of food products while maintaining quality. The company serves a diverse clientele, focusing on grocery retailers, food manufacturers, and distributors, which allows them to cater to the growing demand for sustainable and high-quality food products globally. The geographical markets served include North America, Europe, and Asia, aligning with regions adopting advanced food technologies.

Aseptia's revenue model is primarily based on the sale of its proprietary food processing services, with clients engaging in contractual agreements that provide revenue through service fees. The company has established partnerships with various food manufacturers to integrate its preservation technology, further enhancing its revenue streams. Specific pricing structures are tailored to meet the varying needs of clients across different service tiers, enabling flexibility and scalability in their offerings. Aseptia, Inc.

aims to expand its market presence by launching new food preservation technologies targeted for release by the end of 2024. The company plans to extend its services into new markets, particularly in Asia and Europe, by mid-2025, leveraging its recent funding. The USD 22. 00 mn raised in the Series C round will be utilized to develop these new products and support the expansion into emerging markets, thereby enhancing its operational capacity and market reach.